Day 4 ASCO 2021 Roundup: Immunotherapy Candidates Show Promise in Early Studies

2021-06-09| R&DTechnology

Day 4 ASCO 2021 Roundup: Immunotherapy Candidates Show Promise in Early Studies

by Daniel Ojeda

Share To

The fourth day of the ASCO 2021 virtual annual meeting featured clinical trial data of some promising immunotherapy candidates. Oncolytic Viral Therapy Shows Promising Results in Fighting T-cell Lymphoma. Joselle Cook, MBBS, from the Mayo Clinic presented the results of Phase 1 clinical trial testing the effects of a novel oncolytic virotherapy against hematological malignancies.

It's free! Log in now to read

LATEST

Exosomes: What They Do and Who’s Doing What

2025-04-21

Eli Lilly’s Orforglipron Shows Phase 3 Success: First Oral GLP-1 Drug for Type 2 Diabetes and Weight Loss

2025-04-21

Dupixent Makes History with FDA Approval as First New CSU Treatment in Over a Decade

2025-04-20

Multiple PCV Doses May Be Needed for Immunocompromised Type 2 Diabetics to Maintain Protection, Study Finds

2025-04-19

Multiple PCV Doses May Be Needed for Immunocompromised Individuals with Type 2 Diabetes

2025-04-19

Dr. Lauren Krupp, FAAN, Advocates Early Intervention and Family Support in Pediatric MS Treatment.

2025-04-19

Dr. Lauren B. Krupp Recommends Early, Aggressive Treatment with High-Efficacy Therapies for Pediatric Multiple Sclerosis

2025-04-19

EVENT

2025-04-21

World Vaccine Congress Washington 2025

Washington, U.S.A

2025-04-21

World Vaccine Congress 2025

Washington, U.S.A

2025-04-25

AACR Annual Meeting 2025

Chicago, U.S.A

2025-04-26

SABPA OC/LA 17th Annual Biomedical Forum

Irvine, California, United States

2025-05-03

29th Taiwan Joint Cancer Conference 2025

Taipei, Taiwan

2025-05-05

Swiss Biotech Day 2025

Basel, Switzerland

Cookie	Duration	Description
cookielawinfo-checbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

GENE ONLINE|News &
Opinion
Blog